Abstract
5-Fluorouracil (5-Fu) and leucovorin (LV) are often given in combination to treat colorectal cancer. 5-Fu/LV prevents cell proliferation by inhibiting thymidylate synthase, which catalyzes the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate. While 5-Fu has been shown to cause cognitive impairment, the synergistic effect of 5-Fu with LV has not been fully explored. The present investigation was designed to assess how the combination of 5-Fu and LV affect cognition in a murine model. Six-month-old male mice were used in this study; 15 mice received saline injections and 15 mice received 5-Fu/LV injections. One month after treatment, the elevated plus maze, Y-maze, and Morris water maze behavioral tasks were performed. Brains were then extracted, cryosectioned, and stained for CD68 to assay microglial activation and with tomato lectin to assay the vasculature. All animals were able to locate the visible and hidden platform locations in the water maze. However, a significant impairment in spatial memory retention was observed in the probe trial after the first day of hidden-platform training (first probe trial) in animals that received 5-Fu/LV, but these animals showed spatial memory retention by day 5. There were no significant increases in inflammation as measured by CD68, but 5-Fu/LV treatment did modulate blood vessel morphology. Tandem mass tag proteomics analysis identified 6,049 proteins, 7 of which were differentially expressed with a p-value of <0.05 and a fold change of >1.5. The present data demonstrate that 5-Fu/LV increases anxiety and significantly impairs spatial memory retention.
Highlights
The development and improvement of chemotherapeutic treatments has led to a higher survival rate for cancer patients
In order to determine if 5-Fu/LV affects cognition, our study consists of two groups of 6-month old C57Bl6/J wild type male mice: 1) a control group that receives only 0.09% Saline (n 15) intraperitoneal injections, and 2) a group that was coadministered 5-Fu (50 mg/kg) + LV (90 mg/kg) (n 15) over a 3-week period on days 1, 8, and 15
To examine anxiety-like behavior in mice treated with 5-Fu/LV, the elevated plus maze task was performed 4 weeks after chemotherapy administration
Summary
The development and improvement of chemotherapeutic treatments has led to a higher survival rate for cancer patients. Cancer survivors that undergo chemotherapeutic treatment often have long-term cognitive impairments referred to as “chemobrain,” or “chemofog.” This cognitive dysfunction is characterized by attention and memory problems, lack of concentration, and difficulties with multi-tasking following chemotherapeutic treatment (Matsuda et al, 2005; Hermelink et al, 2007; Vardy and Tannock, 2007; Hutchinson et al, 2012; Wefel and Schagen, 2012). These symptoms are often only temporary but have been reported to persist for months-to-. The current study utilized aged male mice which are useful for evaluating the impact of chemotherapeutic agents on cognitive functions
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
